Bank of New York Mellon Corp Has $8.82 Million Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

Bank of New York Mellon Corp lessened its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 3.1% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 608,816 shares of the company’s stock after selling 19,461 shares during the period. Bank of New York Mellon Corp owned about 0.71% of Pediatrix Medical Group worth $8,822,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. Principal Financial Group Inc. raised its position in Pediatrix Medical Group by 6.2% during the 1st quarter. Principal Financial Group Inc. now owns 586,190 shares of the company’s stock worth $8,494,000 after purchasing an additional 34,266 shares during the last quarter. Teacher Retirement System of Texas boosted its stake in Pediatrix Medical Group by 92.3% during the 1st quarter. Teacher Retirement System of Texas now owns 371,756 shares of the company’s stock valued at $5,387,000 after purchasing an additional 178,386 shares during the last quarter. New York State Teachers Retirement System boosted its stake in Pediatrix Medical Group by 1.9% during the 1st quarter. New York State Teachers Retirement System now owns 133,313 shares of the company’s stock valued at $1,932,000 after purchasing an additional 2,527 shares during the last quarter. Diversified Trust Co bought a new position in shares of Pediatrix Medical Group during the 1st quarter worth approximately $236,000. Finally, Ritholtz Wealth Management raised its holdings in Pediatrix Medical Group by 73.7% during the 1st quarter. Ritholtz Wealth Management now owns 24,119 shares of the company’s stock valued at $349,000 after acquiring an additional 10,236 shares during the period. Institutional investors own 97.71% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. UBS Group dropped their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating for the company in a report on Monday, May 12th. Macquarie raised their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a report on Thursday, May 8th. Finally, Truist Financial decreased their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 11th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $16.67.

Pediatrix Medical Group Stock Up 0.8%

Shares of Pediatrix Medical Group stock opened at $12.67 on Tuesday. Pediatrix Medical Group, Inc. has a 1 year low of $7.40 and a 1 year high of $17.67. The business has a 50-day moving average of $13.83 and a two-hundred day moving average of $13.87. The company has a market capitalization of $1.09 billion, a P/E ratio of -12.54, a price-to-earnings-growth ratio of 0.85 and a beta of 1.25. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.81 and a quick ratio of 1.81.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.08. The business had revenue of $458.36 million during the quarter, compared to analysts’ expectations of $451.44 million. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The firm’s revenue for the quarter was down 7.4% compared to the same quarter last year. During the same period last year, the firm posted $0.20 EPS. As a group, equities analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.